Literature DB >> 505675

Urine cytology of transitional cell neoplasms.

C C Rife, G M Farrow, D C Utz.   

Abstract

The extrinsic and intrinsic factors which influence the interpretation of cytologic findings are explained in detail. Although plagued by limitations that have yielded false-positive and false-negative results, through research, attempts are being made to improve the efficacy of urine cytology in the detection of neoplasms of the urinary tract.

Entities:  

Mesh：

Year:  1979        PMID： 505675

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  14 in total

1.  The evaluation and management of hematuria in women.

Authors:  H A Winkler; P K Sand
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

2.  Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.

Authors:  Virginia Urquidi; Steve Goodison; Jeongsoon Kim; Myron Chang; Yunfeng Dai; Charles J Rosser
Journal:  Urology       Date:  2012-03-03       Impact factor: 2.649

3.  The reproducibility of cytomorphometrical grading of bladder tumours.

Authors:  H G van der Poel; M E Boon; E A vand er Meulen; A Wijsman-Grootendorst
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 4.  Multimodal management of muscle-invasive bladder cancer.

Authors:  Jong Chul Park; Deborah E Citrin; Piyush K Agarwal; Andrea B Apolo
Journal:  Curr Probl Cancer       Date:  2014-06-23       Impact factor: 3.187

5.  Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer.

Authors:  Satoru Muto; Syo-Ichiro Sugiura; Akiko Nakajima; Akira Horiuchi; Masahiro Inoue; Keisuke Saito; Shuji Isotani; Raizo Yamaguchi; Hisamitsu Ide; Shigeo Horie
Journal:  Int J Clin Oncol       Date:  2013-10-09       Impact factor: 3.402

Review 6.  Urinary proteomic profiling for diagnostic bladder cancer biomarkers.

Authors:  Steve Goodison; Charles J Rosser; Virginia Urquidi
Journal:  Expert Rev Proteomics       Date:  2009-10       Impact factor: 3.940

7.  Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer.

Authors:  Virginia Urquidi; Steve Goodison; Shanti Ross; Myron Chang; Yunfeng Dai; Charles J Rosser
Journal:  J Urol       Date:  2012-10-22       Impact factor: 7.450

8.  Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia.

Authors:  Charles J Rosser; Li Liu; Yijun Sun; Patrick Villicana; Molly McCullers; Stacy Porvasnik; Paul R Young; Alexander S Parker; Steve Goodison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

9.  Urine-based assays for the detection of bladder cancer.

Authors:  Patrick Villicana; Bryant Whiting; Steve Goodison; Charles J Rosser
Journal:  Biomark Med       Date:  2009-06-01       Impact factor: 2.851

10.  A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer.

Authors:  Sijia Huang; Lei Kou; Hideki Furuya; Changhong Yu; Steve Goodison; Michael W Kattan; Lana Garmire; Charles J Rosser
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07-06       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.